Patient Guide: Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 39 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04650581
Status: ACTIVE_NOT_RECRUITING
Condition: Breast Cancer
Phase: PHASE3

Find a Study Location Near You

This study is available at 39 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Bowral, New South Wales
  • Gateshead, New South Wales
  • Gosford, New South Wales
  • • And 36 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily